BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

467 related articles for article (PubMed ID: 27191662)

  • 21. Taurolidine-based catheter lock regimen significantly reduces overall costs, infection, and dysfunction rates of tunneled hemodialysis catheters.
    Winnicki W; Herkner H; Lorenz M; Handisurya A; Kikić Ž; Bielesz B; Schairer B; Reiter T; Eskandary F; Sunder-Plassmann G; Sengoelge G
    Kidney Int; 2018 Mar; 93(3):753-760. PubMed ID: 28890326
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prophylactic antibiotics for preventing Gram positive infections associated with long-term central venous catheters in oncology patients.
    van de Wetering MD; van Woensel JB; Lawrie TA
    Cochrane Database Syst Rev; 2013 Nov; 2013(11):CD003295. PubMed ID: 24277633
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin locks with low and high concentration in haemodialysis patients: A systematic review and meta-analysis.
    Tan J; Ning T; Zhang W; Qian Z; Jiang X; Sun L; Wu B
    Int J Nurs Pract; 2021 Feb; 27(1):e12907. PubMed ID: 33347670
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does the heparin lock concentration affect hemodialysis catheter patency?
    Ivan DM; Smith T; Allon M
    Clin J Am Soc Nephrol; 2010 Aug; 5(8):1458-62. PubMed ID: 20498241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Heparin-bonded catheters for prolonging the patency of central venous catheters in children.
    Shah PS; Shah N
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD005983. PubMed ID: 24569952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heparin flushing and other interventions to maintain patency of central venous catheters: a systematic review.
    Mitchell MD; Anderson BJ; Williams K; Umscheid CA
    J Adv Nurs; 2009 Oct; 65(10):2007-21. PubMed ID: 20568318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hemodialysis catheter locking solutions and the prevention of catheter dysfunction: a meta-analysis.
    Chapla K; Oza-Gajera BP; Yevzlin AS; Shin JI; Astor BC; Chan MR
    J Vasc Access; 2015; 16(2):107-12. PubMed ID: 25262758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of heparinized catheter lock solutions on systemic anticoagulation in hemodialysis patients.
    Thomson PC; Morris ST; Mactier RA
    Clin Nephrol; 2011 Mar; 75(3):212-7. PubMed ID: 21329631
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Safety and efficacy of taurolidine/urokinase versus taurolidine/heparin as a tunneled catheter lock solution in hemodialysis patients: a prospective, randomized, controlled study.
    Al-Ali F; Hamdy AF; Hamad A; Elsayed M; Zafar Iqbal Z; Elsayed A; Ibrahim R; Tolba H; Buanan H; Fawzy A
    Nephrol Dial Transplant; 2018 Apr; 33(4):619-626. PubMed ID: 29106676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulant therapies versus heparin for the prevention of hemodialysis catheter-related complications: systematic review and meta-analysis of prospective randomized controlled trials.
    Liu J; Wang C; Zhao H; Zhang J; Ma J; Hou Y; Zou H
    Int J Clin Exp Med; 2015; 8(8):11985-95. PubMed ID: 26550111
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial.
    Power A; Duncan N; Singh SK; Brown W; Dalby E; Edwards C; Lynch K; Prout V; Cairns T; Griffith M; McLean A; Palmer A; Taube D
    Am J Kidney Dis; 2009 Jun; 53(6):1034-41. PubMed ID: 19394731
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative effectiveness of 30 % trisodium citrate and heparin lock solution in preventing infection and dysfunction of hemodialysis catheters: a randomized controlled trial (CITRIM trial).
    Correa Barcellos F; Pereira Nunes B; Jorge Valle L; Lopes T; Orlando B; Scherer C; Nunes M; Araújo Duarte G; Böhlke M
    Infection; 2017 Apr; 45(2):139-145. PubMed ID: 27573387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients.
    Moore CL; Besarab A; Ajluni M; Soi V; Peterson EL; Johnson LE; Zervos MJ; Adams E; Yee J
    Clin J Am Soc Nephrol; 2014 Jul; 9(7):1232-9. PubMed ID: 24970874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin for prolonging peripheral intravenous catheter use in neonates.
    Shah PS; Ng E; Sinha AK
    Cochrane Database Syst Rev; 2002; (4):CD002774. PubMed ID: 12519576
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin versus 0.9% sodium chloride intermittent flushing for prevention of occlusion in central venous catheters in adults.
    López-Briz E; Ruiz Garcia V; Cabello JB; Bort-Marti S; Carbonell Sanchis R; Burls A
    Cochrane Database Syst Rev; 2014 Oct; (10):CD008462. PubMed ID: 25300172
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients.
    Moran J; Sun S; Khababa I; Pedan A; Doss S; Schiller B
    Am J Kidney Dis; 2012 Jan; 59(1):102-7. PubMed ID: 22088576
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low molecular weight heparin versus unfractionated heparin for perioperative thromboprophylaxis in patients with cancer.
    Akl EA; Kahale L; Sperati F; Neumann I; Labedi N; Terrenato I; Barba M; Sempos EV; Muti P; Cook D; Schünemann H
    Cochrane Database Syst Rev; 2014 Jun; (6):CD009447. PubMed ID: 24966161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Normal saline versus heparin for patency of central venous catheters in adult patients - a systematic review and meta-analysis.
    Zhong L; Wang HL; Xu B; Yuan Y; Wang X; Zhang YY; Ji L; Pan ZM; Hu ZS
    Crit Care; 2017 Jan; 21(1):5. PubMed ID: 28063456
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial.
    Maki DG; Ash SR; Winger RK; Lavin P;
    Crit Care Med; 2011 Apr; 39(4):613-20. PubMed ID: 21200319
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluating the safety and efficacy of argatroban locking solution in the prevention of the dysfunction of haemodialysis central venous catheters: a study protocol for a randomized controlled trial.
    Wang Y; Liu C; Zhang L; Li J; Zhang L; Wang Y; Zhu H; Cao X; Wu D; Wu J; Lin S; Feng Z; Cai G; Chen X; Sun X
    Ann Palliat Med; 2021 Feb; 10(2):2260-2270. PubMed ID: 33549029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.